Curative Effect Comparasion of Venlafaxine and Fluoxetine in Treating Depression.
Meng Qingwei
Abstract
Meng Qingwei
Abstract
Objective To compare the clinical efficacy and safety of venlafaxine and fluoxetine in treating depression.Methods 85 patients with depression were randomly divided into 2 groups: venlafaxine group with 43 patients treated with venlafaxine, 25~100mg, po, bid, for 6wk; fluoxetine group with 42 patients treated with fluoxetine, 20mg, po, qd, for 6wk.Results There was no significant difference in curative effect HAMD scores before and after treatment, side function of the two groups. (P0.05).Conclusion Venlafaxine is a safe and effective drug in treating depression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the clinical efficacy and safety of venlafaxine and fluoxetine in treating depression.Methods 85 patients with depression were randomly divided into 2 groups: venlafaxine group with 43 patients treated with venlafaxine, 25~100mg, po, bid, for 6wk; fluoxetine group with 42 patients treated with fluoxetine, 20mg, po, qd, for 6wk.Results There was no significant difference in curative effect HAMD scores before and after treatment, side function of the two groups. (P0.05).Conclusion Venlafaxine is a safe and effective drug in treating depression.
Key concepts: Venlafaxine, Fluoxetine, Medicine, Hamd, Depression (economics), Anesthesia, Significant difference, Internal medicine